DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2025 | ₹2,969 Cr |
Mar2024 | ₹2,206 Cr |
Mar2023 | ₹2,369 Cr |
Mar2022 | ₹3,881 Cr |
Mar2021 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,969 Cr | 34.59 | |
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹176,643.8 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
MANKIND PHARMA | ₹107,349.0 Cr | -1.5% | 12.7% | 26.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2% |
1.3% |
45.8% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses